These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

720 related items for PubMed ID: 23492603

  • 1. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H, Nammas W, Kervinen K, Mikkelsson J, Pietilä M, Lalmand J, Rivero-Crespo F, Pentikäinen M, Tedjokusumo P, Karjalainen PP.
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [Abstract] [Full Text] [Related]

  • 2. Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial.
    Romppanen H, Nammas W, Kervinen K, Airaksinen JK, Pietilä M, Rivero-Crespo F, Debelder A, Tedjokusumo P, Mikkelsson J, Ylitalo A, Karjalainen PP.
    Ann Med; 2013 Nov; 45(7):488-93. PubMed ID: 24032547
    [Abstract] [Full Text] [Related]

  • 3. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
    Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, Nyman K, Nammas W, Airaksinen KE, Karjalainen PP.
    Int J Cardiol; 2013 Sep 30; 168(2):1214-9. PubMed ID: 23218575
    [Abstract] [Full Text] [Related]

  • 4. Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.
    Nammas W, de Belder A, Niemelä M, Sia J, Romppanen H, Laine M, Karjalainen PP.
    Eur J Intern Med; 2017 Jan 30; 37():43-48. PubMed ID: 27499178
    [Abstract] [Full Text] [Related]

  • 5. A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial.
    Karjalainen PP, Niemelä M, Airaksinen JK, Rivero-Crespo F, Romppanen H, Sia J, Lalmand J, de Bruyne B, Debelder A, Carlier M, Nammas W, Ylitalo A, Hess OM, BACE-ACS study investigators.
    EuroIntervention; 2012 Jul 20; 8(3):306-15. PubMed ID: 22829506
    [Abstract] [Full Text] [Related]

  • 6. Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.
    Karjalainen PP, Nammas W, Ylitalo A, de Bruyne B, Lalmand J, de Belder A, Rivero-Crespo F, Kervinen K, Airaksinen JKE.
    Int J Cardiol; 2016 Nov 01; 222():275-280. PubMed ID: 27497110
    [Abstract] [Full Text] [Related]

  • 7. Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome.
    Sia J, Nammas W, Niemelä M, Airaksinen JK, Lalmand J, Laine M, Tedjokusumo P, Nyman K, Biancari F, Karjalainen PP.
    J Cardiovasc Med (Hagerstown); 2015 Mar 01; 16(3):197-203. PubMed ID: 25003998
    [Abstract] [Full Text] [Related]

  • 8. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Hernádez-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Backx B, Serruys PW.
    JACC Cardiovasc Interv; 2014 Jan 01; 7(1):64-71. PubMed ID: 24332423
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.
    Karjalainen PP, Airaksinen JK, de Belder A, Romppanen H, Kervinen K, Sia J, Laine M, Nammas W.
    Ann Med; 2016 Aug 01; 48(5):376-83. PubMed ID: 27238465
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
    Karjalainen PP, Niemelä M, Laine M, Airaksinen JK, Ylitalo A, Nammas W.
    Am J Cardiol; 2017 Feb 01; 119(3):345-350. PubMed ID: 27887689
    [Abstract] [Full Text] [Related]

  • 11. Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.
    Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, Nyman K, Nammas W, Airaksinen KE, Karjalainen PP.
    J Invasive Cardiol; 2012 Mar 01; 24(3):104-8. PubMed ID: 22388300
    [Abstract] [Full Text] [Related]

  • 12. Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial.
    Nammas W, Airaksinen JKE, Romppanen H, Sia J, de Belder A, Karjalainen PP.
    Angiology; 2017 Jul 01; 68(6):513-518. PubMed ID: 27543565
    [Abstract] [Full Text] [Related]

  • 13. Pooled analysis of two randomized trials comparing titanium-nitride-oxide-coated stent versus drug-eluting stent in STEMI.
    Tuomainen PO, Sia J, Nammas W, Niemelä M, Airaksinen JK, Biancari F, Karjalainen PP.
    Rev Esp Cardiol (Engl Ed); 2014 Jul 01; 67(7):531-7. PubMed ID: 24952392
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.
    Widimsky P, Motovska Z, Belardi J, Serruys P, Silber S, Windecker S, Neumann FJ.
    Int J Cardiol; 2013 Oct 09; 168(4):3522-6. PubMed ID: 23706326
    [Abstract] [Full Text] [Related]

  • 15. Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial.
    Kang WC, Ahn T, Lee K, Han SH, Shin EK, Jeong MH, Yoon JH, Park JS, Bae JH, Hur SH, Rha SW, Oh SK, Kim DI, Jang Y, Choi JW, Kim BO.
    EuroIntervention; 2011 Dec 09; 7(8):936-43. PubMed ID: 21959255
    [Abstract] [Full Text] [Related]

  • 16. 4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
    Karjalainen PP, Niemelä M, Pietilä M, Sia J, de Belder A, Rivero-Crespo F, de Bruyne B, Nammas W.
    Scand Cardiovasc J; 2016 Aug 09; 50(4):218-23. PubMed ID: 27102382
    [Abstract] [Full Text] [Related]

  • 17. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P, Madhavan MV, Mintz GS, Maehara A, Palmerini T, Lasalle L, Xu K, McAndrew T, Kirtane A, Lansky AJ, Brener SJ, Mehran R, Stone GW.
    J Am Coll Cardiol; 2014 May 13; 63(18):1845-54. PubMed ID: 24561145
    [Abstract] [Full Text] [Related]

  • 18. Comparison of long-term outcomes in STEMI and NSTE-ACS after coronary stent placement: an analysis in a real world BMS and DES population.
    van Leeuwen MA, Daemen J, van Mieghem NM, de Boer SP, Boersma E, van Geuns RJ, Zijlstra F, van Domburg RT, Serruys PW, Interventional Cardiologists of the Thoraxcenter 2000–2009.
    Int J Cardiol; 2013 Sep 01; 167(5):2082-7. PubMed ID: 22664371
    [Abstract] [Full Text] [Related]

  • 19. Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.
    Bouisset F, Sia J, Mizukami T, Karjalainen PP, Tonino PAL, Pijls NHJ, Van der Heyden J, Romppanen H, Kervinen K, Airaksinen JKE, Lalmand J, Frambach P, Roza da Costa B, Collet C, De Bruyne B, TIDES-ACS Study Group.
    JAMA Cardiol; 2023 Jul 01; 8(7):703-708. PubMed ID: 37203243
    [Abstract] [Full Text] [Related]

  • 20. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.